相关实验视频
Updated: Jun 3, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.4K
在控制,喘和COPD组中,PM2.5的不同反应刺激了鼻上皮层球状体
Paulina Misiukiewicz-Stępień1, Elwira Zajusz-Zubek2, Katarzyna Górska1
1Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Banacha 1a, Warsaw, 02-097, Poland.
Respiratory research
|January 8, 2025
概括
暴露于空气污染 (PM2.5) 对健康个体和喘或COPD患者的呼吸道表皮有不同的影响. 在阻塞性肺病中,这种改变的反应可能会使疾病恶化恶化.
科学领域:
- 呼吸系统药物 呼吸系统药物
- 环境健康 环境健康
- 细胞生物学 细胞生物学
背景情况:
- 喘和COPD的发病过程涉及呼吸道上皮质的改变.
- 颗粒物 (PM2.5) 暴露与增加的呼吸道疾病发病率和恶化相关.
- 以前存在的肺部疾病可能会改变对环境刺激的上皮反应.
研究的目的:
- 调查PM2.5对健康,喘和COPD呼吸上皮质的影响.
- 用3D球形培养模型比较生物反应.
主要方法:
- 利用来自健康对照组,喘患者和COPD患者的3D球形培养物.
- 在24小时内暴露于PM2.5的100μg/ml的球体.
主要成果:
- 在所有组中,PM2.5诱导了常见的炎症反应 (IL-1β,IL-6,IL-8 mRNA;IL-6分泌).
- 喘表皮显示TNF-α和IL-8的产量较高.
- 慢性肺炎上皮表现出增加的MUC5AC和降低的MMP7mRNA水平,以及改变的AHR和TLR4表达.
结论:
- 呼吸道上皮对PM2.5的反应在健康个体和患有阻塞性肺部疾病的人之间有显著差异.
- 在喘和COPD中,受损的上皮会改变对环境毒素的反应.
- 这些功能障碍可能导致阻塞性肺部疾病的恶化.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K

